This consultancy and assessment is the follow up to the original 2009 SPS report, which described the structure and function of the NMRC, identified challenges in its operations, and provided recommendations for improvements in the NMRC’s processes. In this consultancy, several substantive recommendations are made to enhance the effectiveness and efficiency of the NMRC, particularly in the registration of ARV/AM/ATB medications and to accelerate the processing of medicines on the Namibian EML.
- Strengthening the Capacity of the Namibia Medicines Regulatory Council in the Regulation of Antiretroviral Medicines and Other Essential Pharmaceuticals — View | Download